Early immunological predictors of neurodevelopmental outcomes in HIV-infected children

Clinical Infectious Diseases

Volumn 48, Issue 3, 2009, Pages 338-346

  Mekmullica, Jutarat ^a,i   Brouwers, Pim ^b,c   Charurat, Manhattan ^d   Paul, Mary ^b   Shearer, William ^b   Mendez, Hermann ^f   Diaz, Clemente ^g   Read, Jennifer S ^e   Mondal, Prosanta ^d   Smith, Renee ^h   McIntosh, Kenneth ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMOTOR DEVELOPMENT; VIRUS LOAD;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MENTAL PROCESSES; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE;

EID: 58749084476     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/595885     Document Type: Article

References (39)

1. Wolters P, Brouwers P. Evaluation of neurodevelopmental deficits in children with HIV infection. In: Gendelman HE, Grant I, Lipton SA, Everall I, Swindells S, eds. The neurology of AIDS. 2nd ed. London: Oxford University Press, 2005:667-82.
2. Chase C, Ware J, Hittelman J, et al. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics 2000; 106:E25.
3. Weinberg GA, Burchett SK. Pediatric human immunodeficiency virus infection. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone, 2005:1638-54.
4. Belman AL, Muenz LR, Marcus JC, et al. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: a prospective study from birth to 2 years. Mothers and Infants Cohort Study. Pediatrics 1996; 98:1109-18.
5. Cooper ER, Hanson C, Diaz C, et al. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr 1998; 132:808-12.
6. Nozyce M, Hittelman J, Muenz L, Durako SJ, Fischer ML, Willoughby A. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994; 94:883-91.
7. Lindsey JC, Malee KM, Brouwers P, Hughes MD. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy. Pediatrics 2007; 119:e681-93.
8. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989; 321:1791-6.
9. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ. HIV-1-related encephalopathy in infants compared with children and adults. French Pediatric HIV Infection Study and the SEROCO Group. Neurology 2000; 54:1089-95.
10. Brouwers P, Tudor-Williams G, DeCarli C, et al. Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease. AIDS 1995; 9:713-20.
11. Macmillan C, Magder LS, Brouwers P, et al. Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women. Neurology 2001; 57:1402-11.
12. Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 1999; 341:77-84.
13. Smith R, Malee K, Charurat M, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J 2000; 19:862-71.
14. Sei S, Stewart SK, Farley M, et al. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996; 174:1200-6.
15. Brouwers P, Civitello L, DeCarli C, Wolters P, Sei S. Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. J Neurovirol 2000; 6:390-7.
16. Marcotte TD, Deutsch R, McCutchan JA, et al. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol 2003; 60:1406-12.
17. + lymphocytes and neopterin are related to HIV-encephalopathy. Scand J Psychol 1994; 35:230-9.
18. + T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Pediatrics 2003; 111:e168-75.
19. McCloskey TW, Kohn N, Lesser M, Bakshi S, Pahwa S. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets. Cytometry 2001; 46:157-65.
20. + T-cell subsets in HIV-infected rapid progressor children versus non-rapid progressor children. J Allergy Clin Immunol 2001; 108:258-64.
21. Than S, Kharbanda M, Chitnis V, Bakshi S, Gregersen PK, Pahwa S. Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children. J Immunol 1999; 162:3680-6.
22. + T cells as a prognostic marker in vertically HIV-infected pediatric patients. Pediatr Res 2002; 51:740-5.
23. Paul ME, Mao C, Charurat M, et al. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol 2005; 115:848-55.
24. Sheon A, Fox H, Rich K. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study design, methods, and baseline data. J Womens Health 1996; 5:69-78.
25. Rodriguez EM, Mendez H, Rich K, et al. Maternal drug use in perinatal HIV studies. The Women and Infants Transmission Study. Ann N Y Acad Sci 1993; 693:245-8.
26. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group. J Infect Dis 1994; 170:996-1000.
27. Bayley N. Manual for the Bayley scales of infant development. San Antonio, TX: Psychological Corporation, 1969.
28. Mayes SD. Potential problems using Bayley scales of infant development-II mental scale. J Early Infancy 1997; 2:36-44.
29. Lindsey JC, O'Donnell K, Brouwers P. Methodological issues in analyzing psychological test scores in pediatric clinical trials. J Dev Behav Pediatr 2000; 21:141-51.
30. Paxton H, Kidd P, Landay A, et al. Results of the flow cytometry ACTG quality control program: analysis and findings. Clin Immunol Immunopathol 1989; 52:68-84.
31. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993; 14:702-15.
32. Rich KC, Brambilla D, Pitt J, et al. Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection. Clin Immunol Immunopathol 1997; 85:273-81.
33. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 1994; 43(RR-12):1-19.
34. Diggle PJ. An approach to the analysis of repeated measurements. Biometrics 1988; 44:959-71.
35. McCrossan M, Marsden M, Carnie FW, et al. An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 2006; 129:503-16.
36. McCloskey TW, Cavaliere T, Bakshi S, et al. Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults. Clin Immunol Immunopathol 1997; 84:46-55.
37. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 Study. J Allergy Clin Immunol 2003; 112:973-80.
38. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993; 6:904-12.
39. + T-cell subset in kidney transplant recipients. Transplantation 1998; 65:279-82.